The content on this site is intended for healthcare professionals only
Dr Gilberto Morgan introduces the first day (23rd January) of the 2022 OncoAlert Colloquium.
Day one of the Colloquium focusing on the best in Breast Cancer 2022 and hosts the following key speakers:
Dr Erika Hamilton (Sarah Cannon Institute, Nashville, USA) presenting on 'Advanced Hormone Receptor Positive HER2 positive breast cancer'.
Dr Hope Rugo (UCSF, San Francisco, USA) presenting on 'Advanced Triple negative breast cancer'.
Ms Janice Cowden (USA) presenting on 'Giving us the The Patient Perspective Breast Cancer'.
Dr Evandro de Azambuja (Inst. Jules Bordet, Bruxelles, Belgium) presenting on 'Early hormone receptor positive Her2 positive breast cancer'.
Dr Maryam Lustberg (Yale Cancer, New Haven, USA) presenting on 'Early triple negative breast cancer'.
Ms Jo Taylor (Patient advocate) on 'ABC Diagnosis'.
Dr Icro Meattini (University of Florence, Florence, Italy) presenting on 'Breast Cancer Radiation Oncology on the ASTRO Session'.
Dr Stephanie Graff (Brown University, Providence, USA) discussing 'Current Controversies and future trends in Breast Cancer Research'.
Dr Matteo Lambertini (University of Genova, Genoa, Italy) presenting on 'Fertility Preservation'.
Ending with a SIOG session by Dr KL Cheung (University of Nottingham, Nottingham, UK) presenting on 'Comparing Surgery Vs Endocrine Therapy in early operable Breast Cancer'.
Gaza's cancer patients: Navigating the dual struggle of illness and war
Cancer in emergencies: What can we do better to protect the most vulnerable?
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
Grand Rounds: Improving quality of patient-centred care
Choosing Wisely in radiology Tanzania
Neo-adjuvant therapy for different cancers in the Philippines
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer
Advancing breast cancer diagnosis in the developing world
Global adoption of single-shot targeted IORT for breast cancer
